Cardiology Letters 2017, 26(5):276-281
Mortality of patients with acute pulmonary embolism
- V. interná klinika Lekárská fakulta Univerzita Komenského v Bratislave a UNB, Nemocnica Ruľinov, Bratislava, Slovenská republika
Aim: Acute pulmonary embolism is a relatively common and potentially fatal disease. The authors aim to examine 30-day mortality of patients with the suspicion of pulmonary embolism.
Patients and methods: 286 patients admitted to hospital with dyspnea were accepted in the study. Apart from 30-day mortality the authors observed the correlations of some laboratory parameters commonly tested in a patient presenting with dyspnea (i.e. CRP, D-dimer, Troponin T, NTproBNP) with the diagnosis of pulmonary embolism and with 30-day mortality in the subgroup with approved pulmonary embolism, or in the subgroup without pulmonary embolism.
Results: In the observed 286 patients we found 175 cases of pulmonary embolism, while in 111 cases the CT-pulmoangiography was negative. The only statistically significant difference was observed in levels of D-dimer (4.995 ug/ml in patients without pulmonary embolism vs. 7.456 ug/ml in patients with pumonary embolism, p=0.0001) and in levels of CRP (48.828 mg/l vs. 55.963 mg/l, p=0.0032). In the group with proved pulmonary embolism the 30-day mortality rate was 3.61% (6 patients), while in the group without PE the mortality rate was 17.4% (16 patients), p=0.0002. The impact of observed parameters on mortality rate in the subgroup with approved pulmonary embolism could not be evaluated due to the small number of patients who died. In the subgroup of patients without pulmonary embolism the impact of observed laboratory parameters on 30-day mortality was not observed.
Conclusion: The negative result of CT pulmoangiography in dyspnea patients with suspicion of pulmonary embolism represented a higher risk of death within 30 days after the CT examination (3.61% vs 17.4% patients, p=0.0002).
Keywords: venous thromboembolism; pulmonary embolism; 30-day mortality
Published: May 1, 2017 Show citation
References
- Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007;98(4):756-764.
Go to original source... - Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 esc guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35:3033-3069.
Go to original source... - Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism, Am J Respir Crit Care Med. 2005;172:1041-1046.
Go to original source... - Maggioni AP, Dahlstrom U, Filippatos G, et al. EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail 2013;15:808-817.
Go to original source... - Brown SM, Jones BE, Jephson AR, et al. Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia. Crit Care Med. 2009 Dec. 37(12):3010-3016.
Go to original source... - Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003 May. 58(5):377-382.
Go to original source... - Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997; Jan 23. 336(4):243-250.
Go to original source... - Righini M., Goehring C, Bounameaux H, et al. Effects of age on the performance of common diagnostic tests for pulmonary embolism. Am J Med, Oct 01 2000;109(5):357-361.
Go to original source... - Polo Friz H, Buzzini C, Orenti A, et al. Prognostic value of D-dimer in elderly patients with Pulmonary Embolism. J Thromb Thrombolysis. 2016 Oct;42(3):386-392. doi: 10.1007/s11239-016-1394-8.
Go to original source... - Horvei LD, Grimnes G, Hindberg K, et al. C-reactive protein, obesity, and the risk of arterial and venous thrombosis. J Thromb Haemost. 2016 Aug;14(8):1561-1571.
Go to original source... - Olson NC, Cuchman M, Lutsev PL, et al.Inflammation markers and incident venous thromboembolism: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort. J Thromb Haemost. 2014 Dec;12(12):1993-2001.
Go to original source... - Tsai AW, Cushman M, Rosamond WD, et al. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med. 2002 Dec 1;113(8):636-642.
Go to original source... - Vormittag R, Vukovich T, Schonauer V, et al. Basal high-sensitivityC-reactive protein levels in patients with spontaneous venous thromboembolism. Thromb Haemost. 2005 Mar;93(3):488-493.
Go to original source... - Petrovic T, Koller T, Stvrtinova V, Payer J. Cancer as a risk factor for residual pulmonary embolism.. Int Angiol. 2012 Jun;31(3):283288.
- Bajaj A, Rathor P, Sehgal V, et al. Prognostic Value of Biomarkers in Acute Non-massive Pulmonary Embolism: A Systematic Review and Meta-analysis. Lung. 2015 Oct;193(5):639-651. doi: 10.1007/s00408-015-9752-4. Epub 2015 Jul 2
Go to original source... - Lobo JL, Zorrilla V, Nieto AJ, et al. (2014) Right atrial size and 30-day mortality in normotensive patients with pulmonary embolism. J Pulm Respir Med 2014:218. doi:10.4172/2161105X.1000218
- Fonarow GC, Adams KF, Abraham WT, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293:572580.
Go to original source... - Lenzi J, Avaldi VM, Hernandez-Boussard T, et al. Risk-adjustment models for heart failure patients' 30-day mortality and readmission rates: the incremental value of clinical data abstracted from medical charts beyond hospital discharge record. BMC Health Serv Res. 2016;16(1):473.
Go to original source... - Garcia-Vidal C, Fernández-Sabé N, Carratalà J, et al. Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur Respir J 2008;32:733-739.
Go to original source... - Tashiro M, Fushimi K, Takazono T, et al. A mortality prediction rule for non-elderly patients with community-acquired pneumonia. BMC Pulmonary Medicine. 2016;16:39. doi:10.1186/s12890-016-0199-z.
Go to original source... - Ruhnke GW, Coca-Perraillon M, Kitch BT, Cutler DM. Marked improvement in 30-day mortality among elderly inpatients and outpatients with community-acquired pneumonia. The Am J Med. 2011;124(2):171-178.e1. doi:10.1016/j.amjmed.2010.08.019.
Go to original source...

